William Z. Potter

Alzheimer's Association — United States

Medicine · Health Sciences

63h-index21.7kcitations257works10.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(55), Dementia and Cognitive Impairment Research(51), Treatment of Major Depression(40), Neurotransmitter Receptor Influence on Behavior(36), Bipolar Disorder and Treatment(27)

Publications239 total

Plasma biomarkers in neuropsychiatric syndromes: A narrative review
Journal of Alzheimer s Disease·2025Open Access
Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
Translational Psychiatry·2025· 3 citedOpen Access
Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease
JAMA Neurology·2025· 2 cited
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau <scp>PET</scp> Clocks
Annals of Neurology·2025· 12 citedOpen Access
Machine Learning-Enabled EEG Biomarkers Predict Divergent Antidepressant and Placebo Response in a Clinical Trial of Major Depression
2025· 2 citedOpen Access
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts
GeroScience·2025· 2 cited
Head‐to‐head evaluation of leading blood tests for amyloid pathology
Alzheimer s & Dementia·2024Open Access
Timing of changes in Alzheimer’s disease plasma biomarkers as assessed by amyloid and tau PET clocks
2024· 2 citedOpen Access
Head‐to‐head comparison of leading blood tests for Alzheimer's disease pathology
Alzheimer s & Dementia·2024· 116 citedOpen Access
The origins of ADNI
Alzheimer s & Dementia·2024· 5 citedOpen Access
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population
JAMA Neurology·2024· 4 citedOpen Access
Head-to-head comparison of leading blood tests for Alzheimer's disease pathology
2024· 9 citedOpen Access
Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
Translational Psychiatry·2024· 4 citedOpen Access
Public–Private Partnerships for Neuropsychiatric Drug Development: A Perspective
Advances in neurobiology·2024
Update to the comparative analytical performance of plasma Aβ assays and their relationship to amyloid PET
Alzheimer s & Dementia·2023Open Access
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains
Brain·2023· 19 citedOpen Access
Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females
Brain·2023· 34 citedOpen Access
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease
JAMA Neurology·2023· 77 citedOpen Access
Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer’s disease: an exploratory study of 18F-FDG-PET
GeroScience·2023· 13 citedOpen Access
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
JAMA Neurology·2023· 45 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Clifford R. Jack(21), Arthur W. Toga(21), John C. Morris(21), John Q. Trojanowki(18), Laurel Beckett(18), Andrew J. Saykin(18), Michael W. Weiner(17), William J. Jagust(17), Leslie M. Shaw(16), Robert C. Green(16), Peter J. Snyder(15), Michael Donohue(14), Magdalena Korecka(13), Tom Montine(12), Sarah Walter(12), Matt A. Bernstein(12), Nick C. Fox(12), Paul M. Thompson(12), Norbert Schuff(12), Robert A. Koeppe(12)